Zenith Drugs IPO: Check Subscription Status, GMP Today.
Unlisted shares of Zenith Drugs Ltd are buying and selling Rs 17 greater within the gray market, anticipating 21.52 per cent itemizing acquire from the general public difficulty
Zenith Drugs IPO: The preliminary public providing of pharma firm Zenith Drugs Ltd, which was opened for public subscription on Monday, February 19, is receiving a optimistic response from buyers. Till 11:02 am on the third day of bidding on Wednesday, the Rs 40.68-crore SME IPO obtained 7.59 occasions subscription, garnering bids for two,28,32,000 shares as towards 30,08,000 shares on supply.
The IPO might be closed on Thursday, February 22.
The retail class has obtained 11.79 occasions subscription and the non-institutional quota received 3.20 occasions subscription. The certified institutional purchaser (QIB) class has obtained 3.53 occasions subscription.
The allotment of Zenith Drugs IPO will happen on February 23, whereas its itemizing will happen on the NSE SME on February 27, 2024.
Zenith Drugs IPO GMP Today
According to market observers, unlisted shares of Zenith Drugs Ltd are buying and selling Rs 17 greater within the gray market as in contrast with its difficulty worth. The Rs 17 gray market premium or GMP means the gray market is anticipating a 21.52 per cent itemizing acquire from the general public difficulty. The GMP relies on market sentiments and retains altering.
‘Grey market premium’ signifies buyers’ readiness to pay greater than the problem worth.
Zenith Drugs IPO Details
The Zenith Drugs IPO is totally a contemporary difficulty of 51.49 lakh shares. The worth band of the IPO has been fastened at Rs 75 to Rs 79 per share.
The minimal lot dimension for an software is 1,600 shares. The minimal quantity of funding required by retail buyers is Rs 1,26,400. The minimal lot dimension funding for HNI is 2 heaps (3,200 shares) amounting to Rs 2,52,800.
Gretex Corporate Services Limited is the ebook-working lead supervisor of the Zenith Drugs IPO, whereas Bigshare Services Pvt Ltd is the registrar for the problem. The market maker for Zenith Drugs IPO is Gretex Share Broking.
